Limulus Amebocyte Lysate Industry Trends

Limulus Amebocyte Lysate Industry Trends

Thursday, January 2, 2014

FDA Adopts New Standard to Allow for Interchangeable Endotoxin Testing Between ICH Regions

FDA Adopts New Standard to Allow for Interchangeable Endotoxin Testing Between ICH Regions
Posted by Unknown at 5:34 PM
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

Blog Archive

  • ▼  2014 (13)
    • ►  May (1)
    • ▼  January (12)
      • Hyglos endotoxin detection presentations and visit...
      • Innovative Endotoxin Removal in Biomanufacturing P...
      • Mycoplasma Detection Simplified by Endotoxin Testi...
      • Evaluation of the endotoxin binding efficiency of ...
      • Recombinant Factor C Technology in Endotoxin Detec...
      • ICH Guideline Q4B Annex 14: Bacterial Endotoxins Test
      • FDA Adopts New Standard to Allow for Interchangeab...
      • Pharmaceutical Microbiology: Endotoxin detection: ...
      • Recombinant Factor C Endotoxin Detection Presentat...
      • Comparison of the pyrogen tests in rabbits and wit...
      • History of the LAL Test : Validation and Regulator...
      • Limulus Amebocyte Lysate from Wikipedia

About Me

Unknown
View my complete profile
Simple theme. Powered by Blogger.